UBS raised the firm’s price target on Axon (AXON) to $840 from $820 and keeps a Neutral rating on the shares. Axon’s growth reaccelerated in Q2, the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AXON:
- Axon upgraded to Buy from Hold at Craig-Hallum
- Axon Enterprise’s Strong Growth Potential and Increased Price Target Amid Surpassing Revenue Expectations
- Axon Enterprise’s Strong Financial Performance and Strategic Growth Drive Buy Rating
- Axon Enterprise Reports Strong Q2 2025 Growth
- Axon Enterprise’s Strong Revenue Growth and Bookings Performance Justify Buy Rating and Increased Price Target